Document Detail


Pancreastatin modulates glucose-stimulated insulin secretion from the perfused rat pancreas.
MedLine Citation:
PMID:  8876749     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pancreastatin is known to be produced in islet B cells and to inhibit insulin secretion. In this study, we examined whether the peptide affects insulin secretion from the perfused rat pancreas during raising or lowering the glucose concentration within the physiological range. We found that synthetic porcine pancreastatin (15 nmol L-1) significantly inhibited the first phase (5 min) of insulin release induced by raising the glucose concentration from 4.2 to 8.3 mmol L-1 (P < 0.05) without affecting the second phase. Furthermore, the fall in insulin secretion induced by lowering the glucose concentration from 8.3 to 5.5 mmol L-1 was significantly exaggerated in presence of pancreastatin during the first 5 min (P < 0.05). In contrast, pancreastatin did not affect the inhibition of insulin secretion induced by either the alpha 2-adrenoceptor agonist, clonidine (2 nmol L-1), or the P1-purinoceptor (A1-subtype) agonist, N6 (+)-phenylisopropyladenosine (D-PIA) (1.65 mumol L-1). In conclusion, our results show that pancreastatin is a modulator of the early changes in insulin secretion after increase or decrease of the glucose concentration within the physiological range. This suggests that pancreastatin is a modulator of glucose-stimulated insulin secretion.
Authors:
B Ahrén; G Bertrand; M Roye; G Ribes
Related Documents :
17639599 - High glucose stimulates gro secretion from rat microglia via ros, pkc, and nf-kappab pa...
4914679 - Synthesis and release of proinsulin and insulin by isolated rat islets of langerhans.
3334729 - Protease inhibitors decrease rabbit cartilage degradation after meniscectomy.
21796809 - Effects of glut4 expression on insulin resistance in patients with advanced liver cirrh...
2168179 - Evidence for a role of microfilaments in insulin release from purified beta-cells.
1541239 - Release of amylin from perfused rat pancreas in response to glucose and glucagon.
21674179 - Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant abcc8/kcnj11 muta...
7729789 - Blunted gh response to growth hormone-releasing hormone (ghrh) alone or combined with a...
2391299 - Amyotrophy in young diabetics: clinical profiles.
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta physiologica Scandinavica     Volume:  158     ISSN:  0001-6772     ISO Abbreviation:  Acta Physiol. Scand.     Publication Date:  1996 Sep 
Date Detail:
Created Date:  1997-01-23     Completed Date:  1997-01-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370362     Medline TA:  Acta Physiol Scand     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  63-70     Citation Subset:  IM    
Affiliation:
Department of Medicine, Lund University, Malmö, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Agonists / pharmacology
Animals
Blood Glucose / metabolism
Clonidine / pharmacology
Glucose / pharmacology*
Insulin / secretion*
Male
Pancreas / drug effects,  secretion*
Pancreatic Hormones / antagonists & inhibitors,  pharmacology*
Phenylisopropyladenosine / pharmacology
Rats
Rats, Wistar
Receptors, Purinergic P1 / antagonists & inhibitors
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 0/Blood Glucose; 0/Pancreatic Hormones; 0/Receptors, Purinergic P1; 106477-83-2/pancreastatin; 11061-68-0/Insulin; 29193-86-0/Phenylisopropyladenosine; 4205-90-7/Clonidine; 50-99-7/Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characteristics of fasting and fed myoelectric activity in rat small intestine: evaluation by comput...
Next Document:  Perchlorate is hypoglycaemic by amplifying glucose-stimulated insulin secretion in mice.